Teva Pharm to pay Oklahoma $85 million to settle opioid claims
BOSTON/JERUSALEM (Reuters) - Teva Pharmaceutical Industries said on Sunday it had agreed an $85 million settlement with the state of Oklahoma days before the company was set to face trial over allegations that it and other drugmakers helped to fuel the U.S. opioid epidemic. Teva, the world's largest generic drugmaker, said the settlement "does not establish any wrongdoing on the part of the company" and denied contributing to opioid abuse in Oklahoma.
The post Teva Pharm to pay Oklahoma $85 million to settle opioid claims appeared first on Firstpost.